申请人:Fukuda Yasumichi
公开号:US20050038092A1
公开(公告)日:2005-02-17
This invention relates to new oxazolidinones having a cyclopropyl moiety, which are effective against aerobic and anerobic pathogens such as multi-resistant
staphylococci, streptococci
and
enterococci, Bacteroides
spp.,
Clostridia
spp. species, as well as acid-fast organisms such as
Mycobacterium tuberculosis
and other mycobacterial species.
The compounds are represented by structural formula I:
its enantiomer, diastereomer, or pharmaceutically acceptable salt or ester thereof.
本发明涉及新的含有环丙基基团的噁唑烷酮,对于耐药性较强的革兰氏阳性菌(如多重耐药金黄色葡萄球菌、链球菌和肠球菌)、Bacteroides属、Clostridia属物种以及酸性快速生长菌(如结核分枝杆菌和其他分枝杆菌物种)等厌氧和需氧病原体具有良好的抗菌作用。所述化合物由结构式I表示,其对映异构体、不对称异构体或其药学上可接受的盐或酯。